Arsenic in drinking water and bladder cancer: review of epidemiological evidence

Trace Metals and other Contaminants in the Environment

Volumn 9, Issue , 2007, Pages 551-584

  Meliker, J R ^a   Nriagu, J O ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTIANA TABACUM;

EID: 44349161638     PISSN: 18751121     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1875-1121(06)09021-3     Document Type: Review

References (128)

1. Adams M.A., Bolger P.M., and Gunderson E.L. Dietary intake and hazards of arsenic. In: Chappell W.R., Abernathy C.O., and Cothern C.R. (Eds). Arsenic Exposure and Health (1994), Science and Technology Letters, Northwood, UK 41-49
2. Andrew A.S., Karagas M.R., and Hamilton J.W. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. International Journal of Cancer 104 (2003) 263-268
3. Apostoli P., Bartoli D., Alessio L., et al. Biological monitoring of occupational exposure to inorganic arsenic. Occupational and Environmental Medicine 56 (1999) 825-832
4. Backer D.E., and Chesnin L. Chemical monitoring of soils for environment quality and animal and human health. Advances in Agronomy 27 (1975) 305-374
5. Bae M., Watanabe C., Inaoka T., et al. Arsenic in cooked rice in Bangladesh. Lancet 260 (2002) 1839-1840
6. Basu A., Mahata J., Roy A.K., et al. Enhanced frequency of micronuclei in individuals exposed to arsenic through drinking water in West Bengal, India. Mutation Research 516 (2002) 29-40
7. Bates M.N., Smith A.H., and Cantor K.P. Case-control study of bladder cancer and arsenic in drinking water. American Journal of Epidemiology 141 (1995) 523-530
8. Bates M.N., Rey O.A., Biggs M.L., et al. Case-control study of bladder cancer and exposure to arsenic in drinking water in Argentina. American Journal of Epidemiology 159 (2004) 381-389
9. Bernstam L., Lan C.-H., Lee J., et al. Effects of arsenic on human keratinocytes: morphological, physiological, and precursor incorporation studies. Environmental Research Section A 89 (2002) 220-235
10. BGS/DPHE (2001) Arsenic contamination of groundwater in Bangladesh'. In: Kinniburgh, D. G., Smedley, P. L. (eds.) British Geological Survey Technical Report, WC/00/19, Vol. 2, Keyworth, UK.
11. Bode A.M., and Dong Z. The paradox of arsenic, molecular mechanisms of cell transformation and chemotherapeutic effects. Critical Reviews in Oncology/Hematology 42 (2002) 5-24
12. Bode A.M., and Dong Z. Post-translational modification of p53 in tumorigenesis. Nature Reviews Cancer 4 (2004) 793-805
13. Bruemmer B., White E., Vaughan T.L., et al. Fluid intake and the incidence of bladder cancer among middle-aged men and women in a three-county area of Western Washington. Nutrition and Cancer 29 (1997) 163-168
14. Buchet J.P., and Lison D. Mortality by cancer in groups of the Belgian population with a moderately increased intake of arsenic. International Archives of Occupational and Environmental Health 71 (1998) 125-130
15. Calderon R.L. The epidemiology of chemical contaminants of drinking water. Food and Chemical Toxicology 38 (2000) S13-S20
16. Canadian Food Inspection Agency. Fact Sheet, Inorganic Arsenic and Hijiki Seaweed Consumption. Available at (2001). http://www.inspection.gc.ca/english/corpaffr/foodfacts/arsenice.shtml
17. Cantor K.P. Invited commentary: arsenic and cancer of the urinary tract. American Journal of Epidemiology 153 (2001) 419-421
18. Cantor K.P., Lynch C.F., Hildesheim M.E., et al. Drinking water source and chlorination byproducts I. Risk of bladder cancer. Epidemiology 9 (1997) 21-28
19. Chen C.J., and Wang C.J. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Research 50 (1990) 5470-5474
20. Chen C.J., Chuang Y.C., Lin T.M., et al. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Research 45 (1985) 5895-5899
21. Chen C.J., Chuang Y.C., You S.L., et al. A retrospective study of malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. British Journal of Cancer 53 (1986) 399-405
22. Chen C.J., Hsueh Y.M., and Lai M.S. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25 (1995) 53-60
23. Chen Y.C., Su H.J.J., Guo Y.L.L., et al. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes and Control 14 (2003) 303-310
24. Chen C.J., Hsu L.I., Wang C.H., et al. Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan. Toxicology and Applied Pharmacology 206 (2005) 198-206
25. Chiang H.S., Guo H.R., Hong C.L., et al. The incidence of bladder cancer n the black foot disease endemic area in Taiwan. British Journal of Urology 71 (1993) 274-278
26. Chiou H.Y., Huang W.I., Su C.L., et al. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 28 (1997) 1717-1723
27. Chiou H.Y., Hsueh Y.M., Hsieh L.L., et al. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutation Research 386 (1997) 197-207
28. Chiou H.Y., Chiou S.T., Hsu Y.S., et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area of Northeastern Taiwan. American Journal of Epidemiology 153 (2001) 411-418
29. Chow N.H., Guo Y.L., Lin J.S.N., et al. Clinicopathological features of bladder cancer associated with chronic exposure to arsenic. British Journal of Cancer 75 (1997) 1708-1710
30. Cohen S.M., Shirai T., and Steineck G. Epidemiology and etiology of premalignant and malignant urolethial changes. Scandinavian Journal of Urology and Nephrology Supplement 205 (2000) 105-115
31. Cuzick J., Sasieni P., and Evans S. Ingested arsenic, keratoses, and bladder cancer. American Journal of Epidemiology 136 (1992) 417-421
32. Delgado-Andrade C., Navarro M., Lopez H., et al. Determination of total arsenic levels by hydride generation atomic absorption spectrometry in foods from south-east Spain: estimation of daily dietary intake. Food Additives and Contaminants 20 (2003) 923-932
33. Del Razo L.M., Garcia-Vargas G.G., Garcia-Salcedo J., et al. Arsenic levels in cooked food and assessment of adult dietary intake of arsenic in the Region Lagunera, Mexico. Food and Chemical Toxicology 40 (2002) 1423-1431
34. Dhillon A.S., Meikle S., Peyssonnaux C., et al. A Raf-1 mutant that dissociates MEK/extracellular signal-regulated kinase activation from malignant transformation and differentiation but not proliferation. Molecular and Cellular Biology 23 (2003) 1983-1993
35. Florea A.-M., Yamoah E.N., and Dopp E. Intracellular calcium disturbances induced by arsenic and its methylated derivatives in relation to genomic damage and apoptosis induction. Environmental Health Perspectives 113 (2005) 659-664
36. Fujino Y., Guo X., Liu J., et al. Chronic arsenic exposure and urinary 8-Hydroxy-2'-deoxyguanosine in an arsenic-affected area in Inner Mongolia, China. Journal of Exposure Analysis and Environmental Epidemiology 15 (2005) 147-152
37. Gebel T. Arsenic and drinking water contamination (letter). Science 283 (1999) 1458-1459
38. Gebel T. Confounding variables in environmental toxicology of arsenic. Toxicology 144 (2000) 155-162
39. Geoffroy-Perez B., and Cordier S. Fluid consumption and the risk of bladder cancer: results of a multicenter case-control study. International Journal of Cancer 93 (2001) 880-887
40. Goering P.L., Aposhian H.V., Mass M.J., et al. The enigma of arsenic carcinogenesis: role of metabolism. Toxicological Sciences 49 (1999) 5-14
41. Gonsebatt M.E., Vega L., Salazar A.M., et al. Cytogenetic effects in human exposure to arsenic. Mutation Research 386 (1997) 219-228
42. Griffin H.R., Hocking M.B., and Lowery D.G. Arsenic determination in tobacco by atomic absorption spectrometry. Analytical Chemistry 47 (1975) 229-233
43. Guo H.R., and Tseng Y.C. Arsenic in drinking water and bladder cancer: comparison between studies based on cancer registry and death certificates. Environmental Geochemistry and Health 22 (2000) 83-91
44. Guo H.R., Chiang H.S., Hu H., et al. Arsenic in drinking water and incidence of urinary cancers. Epidemiology 8 (1997) 545-550
45. Harding A., Giles N., Burgess A., et al. Mechanism of mitosis-specific activation of MEK1. Journal of Biological Chemistry 278 (2003) 16747-16754
46. Hertz-Picciotto I., Arrighi H.M., and Hu S.W. Does arsenic exposure increase the risk for circulatory disease?. American Journal of Epidemiology 151 (2000) 174-181
47. Hoffmann D., and Hoffmann I. The changing cigarette, 1950-1995. Journal of Toxicology and Environmental Health 50 (1997) 307-364
48. Holland R.H., Wilson R.H., Acevedo A.R., et al. A study of arsenic in regular-sized unfiltered and filtered cigarettes. Cancer 11 (1958) 1115-1118
49. Hopenhayn-Rich C., Biggs M.L., Fuchs A., et al. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 7 (1996) 117-124
50. Hopenhayn-Rich C., Browning S.R., Hertz-Picciotto I., et al. Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environmental Health Perspectives 108 (2000) 667-673
51. Hsu L.I., Wang I.H., Chen C.L., et al. Comparison of chromosomal imbalances detected by comparative genomic hybridization in arsenic-induced and non-arsenic-induced transitional cell carcinoma. Proceedings of Fifth International Conference on Arsenic Exposure and Health Effects'. San Diego, CA, USA (2002) 165
52. Hysong T.A., Burgess J.L., Cebrian Garcia M.E., et al. House dust and inorganic urinary arsenic in two Arizona mining towns. Journal of Exposure Analysis and Environmental Epidemiology 13 (2003) 211-218
53. IARC. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man: Some Metals and Metallic Compounds Vol. 23 (1980), International Agency for Research on Cancer, Lyon, France
54. IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some Drinking-water Disinfectants and Contaminants, Including Arsenic Vol. 84 (2002), International Agency for Research on Cancer, Lyon, France. http://monographs.iarc.fr/htdocs/announcements/vol84.htm
55. Johansson S.L., and Cohen S.M. Epidemiology and etiology of bladder cancer. Seminars in Surgical Oncology 13 (1997) 291-298
56. Karagas M.R., Tosteson T.D., Blum J., et al. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environmental Health Perspectives 106 Suppl. 4 (1998) 1047-1050
57. Karagas M.R., Tosteson T.D., Morris J.S., et al. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes and Control 15 (2004) 465-472
58. Karagas M.R., Park S., Nelson H.T., et al. Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study. International Journal of Hygiene and Environmental Health 208 (2005) 321-327
59. Kaye K.W., and Lange P.H. Mode of presentation of invasive bladder cancer: reassessment of the problem. Journal of Urology 19 (1982) 421-428
60. Kim M.J., Nriagu J., and Haack S. Carbonate ions and arsenic dissolution by groundwater. Environmental Science and Technology 34 (2000) 3094-3100
61. Kitchin K.T. Recent advances in arsenic carcinogenesis: modes of action, animal model systems and methylated arsenic metabolites. Toxicology and Applied Pharmacology 172 (2001) 249-261
62. Koivusalo M., Hakulinen T., Vartiainen T., et al. Drinking water mutagenicity and urinary tract cancers: a population-bases case-control study in Finland. American Journal of Epidemiology 148 (1998) 704-712
63. Kurttio P., Pukkala E., Kahelin H., et al. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environmental Health Perspectives 107 (1999) 705-710
64. Lamm S.H., Engel A., Kruse M.B., et al. Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. counties and 30 years of observation. Journal of Occupational and Environmental Medicine 46 (2004) 298-306
65. Lamont W.H. Concentration of inorganic arsenic in samples of white rice from the United States. Journal of Food Composition and Analysis 16 (2003) 687-695
66. Lasky T., Sun W., Kadry A., et al. Mean total arsenic concentrations in chicken 1989-2000 and estimated exposures for consumers of chicken. Environmental Health Perspectives 112 (2004) 18-21
67. Lewis D.R., Southwick J.W., Ouellet-Hellstromm R., et al. Drinking water arsenic in Utah: a cohort mortality study. Environmental Health Perspectives 107 (1999) 359-365
68. Liu J., Baoshan Z., Aposhian H.V., et al. Chronic arsenic poisoning from burning high-arsenic-containing coal in Guizhou, China. Environmental Health Perspectives 110 (2002) 119-122
69. Lubin J.H., and Fraumeni Jr. J.F. Does arsenic exposure increase the risk for circulatory disease?. American Journal of Epidemiology 152 (2000) 290-293
70. Luster M.I., and Simeonova P.P. Arsenic and urinary bladder cell proliferation: a review. Toxicology and Applied Pharmacology 198 (2004) 419-423
71. Meharg A.A., and Rahman M. Arsenic contamination of Bangladesh paddy field soils: implications for rice contribution to arsenic consumption. Environmental Science and Technology 37 (2003) 229-234
72. Michaud D.S., Spiegelman D., Clinto S.K., et al. Fluid intake and the risk of bladder cancer in men. New England Journal of Medicine 340 (1999) 1390-1397
73. Michaud D.S., Wright M.E., Cantor K.P., et al. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers. American Journal of Epidemiology 160 (2004) 853-859
74. Mills C.J., Bull R.J., Cantor K.P., et al. Health risks of drinking water chlorination byproducts: report of an expert working group. Chronic Diseases in Canada 19 (1998) 91-102
75. MMWR Weekly. Nonfatal arsenic poisoning in three Hmong Patients - Minnesota. June 22 33 (1984) 347-349
76. Moore L.E., Smith A.H., Hopenhayn-Rich C., et al. Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Cancer Epidemiology Biomarkers and Prevention 6 (1997) 31-36
77. Moore L.E., Smith A.H., Hopenhayn-Rich C., et al. Decrease in bladder cell micronucleus prevalence after intervention to lower the concentration of arsenic in drinking water. Cancer Epidemiology Biomarkers and Prevention 6 (1997) 1051-1056
78. Narang A.P., Greval R.S., and Goyal S.C. Arsenic adulteration in Indian tobacco. Indian Journal of Medicine 49 (1995) 55-57
79. NAS. Arsenic in Drinking Water (1999), National Research Council, National Academy of Sciences Press, Washington, DC
80. Noel B. Buerger disease or arsenic intoxication?. Archives of Internal Medicine 161 (2001) 1016
81. Nriagu J.O., and Pacyna J.M. Quantitative assessment of worldwide contamination of the air, water and soils by trace metals. Nature 333 (1988) 134-139
82. Parkash O., and Kiesswetter H. The role of urine in the etiology of cancer of the urinary bladder. Urologia Internationalis 31 (1976) 343-348
83. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. International Journal of Cancer 80 (1999) 827-841
84. Parkin D.M., Pisani P., and Ferlay J. Global Cancer Statistics. CA-A Cancer Journal for Clinicians 49 (1999) 33-64
85. Pinkas J., and Leder P. MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition. Cancer Research 62 (2002) 4781-4790
86. Queirolo F., Stegen S., Restovic M., et al. Total arsenic, lead, and cadmium levels in vegetables cultivated at the Andean Villages of northern Chile. Science of the Total Environment 255 (2000) 75-84
87. Radabaugh T.R., and Aposhian H.V. Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase. Chemical Research in Toxicology 13 (2000) 26-30
88. Radabaugh T.R., Sampayo-Reyes A., Zakharyan R.A., et al. Arsenate reductase II. Purine nucleoside phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. Chemical Research in Toxicology 15 (2002) 692-698
89. Rahman M., Tondel M., Ahmad S.A., et al. Diabetes mellitus associated with arsenic exposure in Bangladesh. American Journal of Epidemiology 148 (1998) 198-203
90. Rahman M., Chowdhury A.S., Fukui T., et al. Association of thromboangiitis obliterans with cigarette and bidi smoking in Bangladesh: a case-control study. International Journal of Epidemiology 29 (2000) 266-270
91. Roychowdhury T., Tokunaga H., and Ando M. Survey of arsenic and other heavy metals in food composites and drinking water and estimation of dietary intake by the villagers from an arsenic-affected area of West Bengal, India. Science of the Total Environment 308 (2003) 15-35
92. Satterlee H.S. The problem of arsenic in American cigarette tobacco. New England Journal of Medicine 254 (1956) 1149-1154
93. Schoof R.A., Yost L.J., Crecelius E., et al. Dietary arsenic intake in Taiwanese districts with elevated arsenic in drinking water. Human and Ecological Risk Assessment 4 (1998) 117-135
94. Schoof R.A., Yost L.J., Eickhoff J., et al. A market basket survey of inorganic arsenic in food. Food and Chemical Toxicology 37 (1999) 839-846
95. Shibata A., Ohneseit P.F., Tsai Y.C., et al. Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan. Carcinogenesis 15 (1994) 1085-1087
96. Shih W.L., Hsu L.I., Chen C.L., et al. Comparison of mutation spectra of p53 gene in arsenic-related and non-arsenic-related transitional cell carcinomas. Proceedings of Fifth International Conference on Arsenic Exposure and Health Effects. San Diego, CA, USA (2002) 163
97. Silverman D.T., Morrison A.S., and Devesa S.S. Bladder Cancer. In: Schottenfeld D., and Fraumeni Jr. J.F. (Eds). Cancer Epidemiology and Prevention (1996), Oxford University Press, New York 1156-1179
98. Simeonova P.P., and Luster M.I. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms?. Journal of Environmental Pathology, Toxicology and Oncology 19 (2000) 281-286
99. Smedley P.L., and Kinniburgh D.G. A review of the source, behavior and distribution of arsenic in natural waters. Applied Geochemistry 17 (2002) 517-568
100. Smith A.H., Hopenhayn-Rich C., Warner M., et al. Rationale for selecting exfoliated bladder cell micronuclei as potential biomarkers for arsenic genotoxicity. Journal of Toxicology and Environmental Health 40 (1993) 223-234
101. Smith C.J., Livingston S.D., and Doolittle D.J. An International literature survey of "IARC Group I Carcinogens" reported in mainstream cigarette smoke. Food and Chemical Toxicology 35 (1997) 1107-1130
102. Smith A.H., Goycolea M., Haque R., et al. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. American Journal of Epidemiology 147 (1998) 660-669
103. Sommers S.C., and McManus R.G. Multiple arsenical cancers of skin and internal organs. Cancer 6 (1952) 347-359
104. Spallholz J.E., Boylan L.M., and Rahman M.M. Environmental hypothesis: is poor dietary selenium intake an underlying factor for arsenicosis and cancer in Bangladesh and West Bengal. India? Science of the Total Environment 323 (2004) 21-32
105. Steinmaus C., Yuan Y., Bates M.N., et al. Case-control study of bladder cancer and drinking water arsenic in the western United States. American Journal of Epidemiology 158 (2003) 1193-1201
106. Taeger D., and Pesch B. Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 US counties and 30 years of observation. Journal of Occupational and Environmental Medicine 46 (2004) 1007-1008
107. Tao S.S.H., and Bolger P.M. Dietary arsenic intakes in the United States: FDA Total Diet Study, September 1991-December 1996. Food Additives and Contaminants 16 (1998) 465-472
108. Thomas D.J., Styblo M., and Lin S. The cellular metabolism and systemic toxicity of arsenic: review. Toxicology and Applied Pharmacology 176 (2001) 127-144
109. Tian D., Ma H., Feng Z., et al. Analyses of micronuclei in exfoliated epithelial cells from individuals chronically exposed to arsenic via drinking water in Inner Mongolia, China. Journal of Toxicology and Environmental Health-Part A 64 (2001) 473-484
110. Tsai S.M., Wang T.N., and Ko Y.C. Mortality for certain diseases in areas with high levels of arsenic in drinking water. Archives of Environmental Health 54 (1999) 186-193
111. Tseng C.H. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environmental Health Perspectives 19 (1977) 109-119
112. Tsuda T., Babazono A., Yamamoto E., et al. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. American Journal of Epidemiology 141 (1995) 198-209
113. Vahter M. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicology Letters 112-113 (2000) 209-217
114. Vahter M., and Concha G. Role of metabolism in arsenic toxicity. Pharmacology and Toxicology 89 (2001) 1-5
115. Villanueva C.M., Fernandez F., Malats N., et al. Meta-analysis of studies on individual consumption of chlorinated drinking water and bladder cancer. Journal of Epidemiology and Community Health 57 (2003) 166-173
116. Vineis P., and Piratsu R. Aromatic amines and cancer. Cancer Causes and Control 8 (1997) 346-355
117. Walker R. Nitrates, nitrites, and N-nitroso compounds: a review of the occurrence in food and diet and the toxicologic implications. Food Additives and Contaminants 7 (1990) 717-768
118. Wang J.P., Qi L., Moore M.R., et al. A review of animal models for the study of arsenic carcinogenesis. Toxicology Letters 133 (2002) 17-31
119. Wang L.H., Chen C.Y., Lee C.Y., Wang I.H., Cheng Y.C., Hsu L.I., Chen C.L., Pu Y.S., and Chen C.J. Comparison of loss of heterozygosity on chromosomes 15 and 16 in arsenic-induced and non-arsenic-induced transitional cell carcinoma. Proceedings of Fifth International Conference on Arsenic Exposure and Health Effects. San Diego, CA, USA (2002) 164
120. Wanibuchi H., Hori T., Meenakshi V., et al. Promotion of rat hepatocarcinogenesis by dimethylarsinic acid: association with elevated ornithine decarboxylase activity and formation of 8-hydroxydeoxyguanosine in the liver. Japanese Journal of Cancer Research 88 (1997) 1149-1154
121. Ward M.H., Cantor K.P., Riley D., et al. Nitrate in public water supplies and risk of bladder cancer. Epidemiology 14 (2003) 183-190
122. Warner M.L., Moore L.E., Smith M.T., et al. Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated drinking water in Nevada. Cancer Epidemiology Biomarkers and Prevention 3 (1994) 583-590
123. Wester R.C., Maibach H.I., Sedik L., et al. In vivo and in vitro percutaneous absorption and skin decontamination of arsenic from water and soil. Fundamental and Applied Toxicology 20 (1993) 336-340
124. Weyer P.J., Cerhan J.R., Kross B.C., et al. Municipal drinking water nitrate level and cancer risk in older women: the Iowa women's health study. Epidemiology 11 (2001) 327-338
125. Yamanaka K., Mizol M., Kato K., et al. Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter. Biological and Pharmaceutical Bulletin 24 (2001) 510-514
126. Yang C.Y., Change C.C., Tsai S.S., et al. Arsenic in drinking water and adverse pregnancy outcome in an arseniasis-endemic area in northeastern Taiwan. Environmental Research 91 (2003) 29-34
127. Zakharyan R.A., Sampayo-Reyes A., Healy S.M., et al. Human monomethylarsonic acid (MMAV) reductase is a member of the glutathione S-transferase superfamily. Chemical Research and Toxicology 14 (2001) 1051-1057
128. Zhong C.X., and Mass M.J. Both hypomethylation and hypermethylation of DNA associated with arsenite exposure in cultures of human cells identified by methylation-sensitive arbitrarily-primed PCR. Toxicology Letters 122 (2001) 223-234